PSNC Briefing 010/19: Reclassification of gabapentin and pregabalin as CDs (March 2019)

This briefing has been compiled to support community pharmacy teams as the reclassification of pregabalin and gabapentin as Schedule 3 Controlled Drugs (CDs) comes into force on 1st April 2019

PSNC Briefing 010/19: Reclassification of gabapentin and pregabalin as CDs (revised 15/04/2019)

If you have any queries on this PSNC Briefing or you require more information, please contact the Dispensing & Supply Team.

To browse other PSNC briefings on dispensing and supply click here.

Latest Dispensing and Supply news

MHRA Drug Safety Update July 2019

Date issued: 17th July 2019 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue...

Shortage Notice: Nardil (phenelzine sulfate) 15mg tablets

Kyowa Kirin, the sole manufacturers of Nardil (phenelzine sulfate) 15mg tablets, are currently experiencing temporary disruptions. Kyowa Kirin, the main...

Shortage Notice: Salbutamol 2mg/5ml syrup

GlaxoSmithKline (GSK) and Pinewood, the manufacturers of Salbutamol 2mg/5ml syrup, are currently experiencing temporary disruptions. GSK, the main supplier of Salbutamol...